| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.026 | 11.957 | 11.515 | 11.196 | 12.086 | 7.050 | 6.934 | 9.743 | 12.315 | 14.866 |
| Total Income - EUR | 13.026 | 11.957 | 11.515 | 11.196 | 12.086 | 7.050 | 6.934 | 9.744 | 12.315 | 14.866 |
| Total Expenses - EUR | 10.198 | 11.631 | 8.603 | 10.832 | 12.876 | 6.846 | 4.860 | 7.719 | 12.707 | 14.652 |
| Gross Profit/Loss - EUR | 2.828 | 326 | 2.912 | 364 | -790 | 204 | 2.074 | 2.025 | -392 | 215 |
| Net Profit/Loss - EUR | 2.437 | 86 | 2.624 | 86 | -911 | 57 | 1.866 | 1.838 | -516 | 180 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dermatonou Pavel Kozak Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 209 | 177 | 145 | 113 | 98 | 87 | 76 | 67 | 31 | 90 |
| Current Assets | 1.456 | 4.574 | 4.593 | 842 | 283 | 254 | 560 | 843 | 366 | 558 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 630 | 3.205 | 3.197 | 258 | 253 | 248 | 242 | 297 | 344 | 548 |
| Cash | 826 | 1.368 | 1.396 | 584 | 30 | 7 | 318 | 546 | 22 | 9 |
| Shareholders Funds | -6.210 | -6.061 | -3.334 | -5.680 | -6.481 | -6.301 | -4.295 | -2.470 | -2.978 | -2.781 |
| Social Capital | 3.458 | 3.423 | 3.365 | 3.303 | 3.239 | 3.178 | 3.107 | 3.117 | 3.107 | 3.090 |
| Debts | 7.875 | 10.811 | 8.071 | 6.635 | 6.862 | 6.643 | 4.932 | 3.381 | 3.376 | 3.430 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dermatonou Pavel Kozak Srl